Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56901 - 56925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Parthenolide	Approved Investigational	VCAM1	7412	downregulated	parthenolide results in decreased expression of VCAM1 mRNA	1p21.2	A23581
Pemetrexed	Approved Investigational	ERCC1	2067	downregulated	Pemetrexed results in decreased expression of ERCC1 mRNA	19q13.32	A23584
Pemetrexed	Approved Investigational	KRAS	3845	downregulated	Pemetrexed results in decreased expression of KRAS mRNA	12p12.1	A23222
Pemetrexed	Approved Investigational	KRAS	3845	downregulated	Pemetrexed results in decreased expression of KRAS mRNA mutant form	12p12.1	A23222
Penicillamine	Approved Investigational	BCL2	596	downregulated	Penicillamine results in decreased expression of BCL2 mRNA	18q21.33	A23585
Penicillamine	Approved Investigational	CAT	847	downregulated	Penicillamine results in decreased expression of CAT mRNA	11p13	A23585
Penicillamine	Approved Investigational	CCL3	6348	upregulated	Penicillamine results in increased expression of CCL3 mRNA	17q12	A23585
Penicillamine	Approved Investigational	CCL4	6351	upregulated	Penicillamine results in increased expression of CCL4 mRNA	17q12	A23585
Penicillamine	Approved Investigational	CYP1A1	1543	upregulated	Penicillamine results in increased expression of CYP1A1 mRNA	15q24.1	A23585
Penicillamine	Approved Investigational	CYP2E1	1571	upregulated	Penicillamine results in increased expression of CYP2E1 mRNA	10q26.3	A23585
Penicillamine	Approved Investigational	DDIT3	1649	upregulated	Penicillamine results in increased expression of DDIT3 mRNA	12q13.3	A23585
Penicillamine	Approved Investigational	EGR1	1958	upregulated	Penicillamine results in increased expression of EGR1 mRNA	5q31.2	A23585
Penicillamine	Approved Investigational	FMO1	2326	upregulated	Penicillamine results in increased expression of FMO1 mRNA	1q24.3	A23585
Penicillamine	Approved Investigational	FMO5	2330	upregulated	Penicillamine results in increased expression of FMO5 mRNA	1q21.1	A23585
Penicillamine	Approved Investigational	GADD45A	1647	upregulated	Penicillamine results in increased expression of GADD45A mRNA	1p31.3	A23585
Penicillamine	Approved Investigational	GSTM3	2947	upregulated	Penicillamine results in increased expression of GSTM3 mRNA	1p13.3	A23585
Penicillamine	Approved Investigational	HMOX1	3162	upregulated	Penicillamine results in increased expression of HMOX1 mRNA	22q12.3	A23585
Penicillamine	Approved Investigational	HSPA1A	3303	upregulated	Penicillamine results in increased expression of HSPA1A mRNA	6p21.33	A23585
Penicillamine	Approved Investigational	HSPA1L	3305	upregulated	Penicillamine results in increased expression of HSPA1L mRNA	6p21.33	A23585
Penicillamine	Approved Investigational	HSPA2	3306	upregulated	Penicillamine results in increased expression of HSPA2 mRNA	14q23.3	A23585
Penicillamine	Approved Investigational	HSPA6	3310	upregulated	Penicillamine results in increased expression of HSPA6 mRNA	1q23.3	A23585
Penicillamine	Approved Investigational	MT1X	4501	downregulated	Penicillamine results in decreased expression of MT1X mRNA	16q13	A21766
Penicillamine	Approved Investigational	NOS2	4843	upregulated	Penicillamine results in increased expression of NOS2 mRNA	17q11.2	A23585
Penicillamine	Approved Investigational	PMAIP1	5366	upregulated	Penicillamine results in increased expression of PMAIP1 mRNA	18q21.32	A23585
Penicillamine	Approved Investigational	PTGS1	5742	upregulated	Penicillamine results in increased expression of PTGS1 mRNA	9q33.2	A23585

Displaying entries 56901 - 56925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability